Showing results (1761-1770 of 2,149) with videos related to
Sort By:
Pageof 215
Journal of Ovarian Research|September 8, 2022
Effects of vitrified cryopreservation duration on IVF and neonatal outcomesYuling Mao, Ni Tang, Yanfen Luo, et al.Journal of Ovarian Research|October 30, 2022
Expression of long noncoding RNAs in the ovarian granulosa cells of women with diminished ovarian reserve using high-throughput sequencingLi Dong, Xin Xin, Hsun-Ming Chang, et al.Journal of Ovarian Research|June 13, 2015
Myo-inositol therapy for poor-responders during IVF: a prospective controlled observational trialFrancesca Caprio, Maria Diletta D'Eufemia, Carlo Trotta, et al.Journal of Ovarian Research|July 25, 2016
The oviductal transcriptome is influenced by a local ovarian effect in the sowRebeca López-Úbeda, Marta Muñoz, Luis Vieira, et al.Journal of Ovarian Research|August 29, 2021
Efficacy of three COS protocols and predictability of AMH and AFC in women with discordant ovarian reserve markers: a retrospective study on 19,239 patientsYaxin Guo, Huahua Jiang, Shiqiao Hu, et al.Journal of Ovarian Research|September 7, 2021
Comprehensive analysis of LASS6 expression and prognostic value in ovarian cancerJinshan Xing, Jingyan YiJournal of Ovarian Research|August 15, 2022
Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancerXin-Ru Li, Xing-Han Cheng, Guo-Nan Zhang, et al.Journal of Ovarian Research|August 13, 2022
Targeting purine metabolism in ovarian cancerJingchun Liu, Shasha Hong, Jiang Yang, et al.Journal of Ovarian Research|August 5, 2022
Incidence, dynamics and recurrences of reverse cleavage in aneuploid, mosaic and euploid blastocysts, and its relationship with embryo qualityLei Jin, Xiyuan Dong, Wei Tan, et al.Journal of Ovarian Research|August 22, 2022
The efficacy and safety of angiogenesis inhibitors for recurrent ovarian cancer: a meta‑analysisChunmei Zhang, Wancheng ZhaoPageof 215